Cytokinetics, Incorporated · NASDAQ:CYTK

Parshall B Lynne sold 5,000 Cytokinetics, Incorporated shares (Form 4)

Traded Nov 9, 2026 · Filed Nov 12, 2026

On Nov 9, 2026, Parshall B Lynne (Director) sold 5,000 Cytokinetics, Incorporated shares at an average US$54.73 for US$274K under a trading plan, leaving 5,784 shares. Filed Nov 12, 2026 (Form 4).

Sold
5,000 shares
Price
US$54.73 average (US$54.17 to US$55.26)
Value
US$274K
Holding after
5,784 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 9, 2026Common StockSale2,445US$54.178,339Direct
Nov 9, 2026Common StockSale2,555US$55.265,784Direct

Source

Download original · View original at SEC

Related